Jaime Contreras, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 52,900 shares at $51.95 ($2.7M) on 2017-09-22, disclosed to the SEC on 2017-09-26.
Open-market sale of $2.7M ABT by Senior Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.95 | 34,400 | $1.8M | 65.0% |
| 2 | $51.96 | 4,152 | $216K | 7.8% |
| 3 | $51.97 | 1,701 | $88K | 3.2% |
| 4 | $51.98 | 1,913 | $99K | 3.6% |
| 5 | $51.99 | 909 | $47K | 1.7% |
| 6 | $52.00 | 1,109 |
| $58K |
| 2.1% |
| 7 | $52.01 | 3,816 | $198K | 7.2% |
| 8 | $52.02 | 1,600 | $83K | 3.0% |
| 9 | $52.02 | 200 | $10K | 0.4% |
| 10 | $52.03 | 500 | $26K | 0.9% |
| 11 | $52.03 | 200 | $10K | 0.4% |
| 12 | $52.04 | 1,200 | $62K | 2.3% |
| 13 | $52.04 | 1,200 | $62K | 2.3% |
| Total | $51.97 avg | 52,900 | $2.7M | 100% |
| Filing → |
| ABT | SELL | 2019-04-24 | $134K | — | Filing → |
| ABT | SELL | 2019-03-04 | $1.9M | — | Filing → |
| ABT | SELL | 2019-02-01 | $12.4M | — | Filing → |